Calimmune and Cincinnati Children's Hospital Medical Center to work together on gene therapies Dec. 7, 2016 No Comments
GlaxoSmithKline begins phase III program for daprodustat in anemia associated with CKD Nov. 25, 2016 No Comments
Boehringer Ingelheim launches idarucizumab as reversal agent for dabigatran in Japan Nov. 21, 2016 No Comments